The coxsackie-adenovirus receptor induces an inflammatory cardiomyopathy independent of viral infection

Journal of Molecular and Cellular Cardiology

Volumn 50, Issue 5, 2011, Pages 826-840

  Yuen, Stella ^a   Smith, Julie ^a   Caruso, Laura ^a   Balan, Marko ^a   Opavsky, Mary Anne ^a,b  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cardiomyopathy; Coxsackie adenovirus receptor; Mitogen activated protein kinases; Myocarditis; Signal transduction

Indexed keywords

COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MYOSIN HEAVY CHAIN ALPHA; RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CARDITIS; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; GENE EXPRESSION; GENOTYPE; HEART MUSCLE CELL; HISTOPATHOLOGY; INFLAMMATORY INFILTRATE; MACROPHAGE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; TRANSGENE; UPREGULATION;

ANIMALS; ANIMALS, NEWBORN; BLOTTING, WESTERN; CARDIOMYOPATHIES; CELLS, CULTURED; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; INTERFERON-GAMMA; INTERLEUKIN-1BETA; INTERLEUKIN-6; MICE; MYOSIN HEAVY CHAINS; PROMOTER REGIONS, GENETIC; RECEPTORS, VIRUS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA;

ADENOVIRIDAE; MURINAE; MUS; MUS MUSCULUS;

EID: 79953678927     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2011.02.011     Document Type: Article

References (56)

1. Bergelson J.M., Cunningham J.A., Droguett G., Horwitz M.S., Wickham T., Crowell R.L., et al. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 1997, 275:1320-1323.
2. Bergelson J.M., Mohanty J.G., Crowell R.L., St.John N.F., Lublin D.M., Finberg R.W. Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55). J Virol 1995, 69:1903-1906.
3. Shafren D.R., Bates R.C., Agrez M.V., Herd R.L., Burns G.F., Barry R.D. Coxsackieviruses B1, B3, and B5 use decay accelerating factor as a receptor for cell attachment. J Virol 1995, 69:3873-3877.
4. Coyne C., Bergelson J. CAR: a virus receptor within the tight junction. Adv Drug Deliv Rev 2005, 57:869-882.
5. Shi Y., Chen C., Lisewski U., Wrackmeyer U., Radke M., Westermann D., et al. Cardiac deletion of the coxsackievirus-adenovirus receptor abolishes coxsackievirus B3 infection and prevents myocarditis in vivo. J Mol Cell Cardiol 2009, 53(14):1219-1226.
6. Roelvink P., Lizonova A., Lee J., Li Y., Bergelson J., Finberg R., et al. The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F. J Virol 1998, 72:7909-7915.
7. Martino T., Petric M., Weingartl H., Bergelson J., Opavsky M., Richardson C., et al. The coxsackie-adenovirus receptor (CAR) is used by reference strains and clinical isolates representing all six serotypes of coxsackievirus group B and by swine vesicular disease virus. Virology 2000, 271:99-108.
8. Ito M., Kodama M., Masuko M., Yamaura M., Fuse K., Uesugi Y., et al. Expression of coxsackievirus and adenovirus receptor in hearts of rats with experimental autoimmune myocarditis. Circ Res 2000, 86:275-280.
9. Fechner H., Noutsias M., Tschoepe C., Hinze K., Wang X., Escher F., et al. Induction of coxsackievirus-adenovirus-receptor expression during myocardial tissue formation and remodeling. Identification of a cell-to-cell contact-dependent regulatory mechanism. Circulation 2003, 107:876-882.
10. Cohen C.J., Sheih J., Pickles R.J., Okegawa T., Hsieh J., Bergelson J. The coxsackie virus and adenovirus receptor is a transmembrane component of the tight junction. Proc Natl Acad Sci USA 2001, 98:15191-15196.
11. Tomko R., Xu R., Philipson L. HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc Natl Acad Sci USA 1997, 94:3352-3356.
12. Bergelson J.M., Krithivas A., Celi L., Droguett G., Horwitz M.S., Wickham T., et al. The murine CAR homolog is a receptor for coxsackie B viruses and adenoviruses. J Virol 1998, 72(1):415-419.
13. Sollerbrant K., Raschperger E., Mirza M., Engstrom U., Philipson L., Ljungdahl P., et al. The coxsackievirus and adenovirus receptor (CAR) forms a complex with the PDZ domain-containing protein ligand-of-numb protein-X (LNX). J Biol Chem 2003, 278:7439-7444.
14. Opavsky M.A., Martino T., Rabinovitch M., Penninger J., Richardson C., Petric M., et al. Enhanced ERK1/2 activation in mice susceptible to coxsackievirus-induced myocarditis. J Clin Invest 2002, 109:1561-1569.
15. Luo H., Yanagawa B., Zhang J., Luo Z., Zhang M., Esfandiarei M., et al. Coxsackievirus B3 replication is reduced by inhibition of the extracellular signal-regulated kinase (ERK) signaling pathway. J Virol 2002, 76:3365-3373.
16. Marchant D., Sall A., Si X., Abraham T., Wu W., Luo Z., et al. ERK MAP kinase-activated Arf6 trafficking directs coxsackievirus type B3 into an unproductive compartment during virus host-cell entry. J Gen Virol 2009, 90:854-862.
17. Lim B., Nam J., Gil C., Yun S., Choi J., Kim D., et al. Coxsackievirus B3 replication is related to activation of the late extracellular signal-regulated kinase (ERK) signal. Virus Res 2005, 113:153-157.
18. Kyriakis J.M., Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 2001 Apr, 81(2):807-869.
19. Derijard B., Hibi M., Wu I., Barrett T., Su B., Deng T., et al. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 1994, 76:1025-1037.
20. Freshney N.W., Rawlinson L., Guesdon F., Jones E., Cowley S., Hsuan J., et al. Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of Hsp27. Cell 1994 Sep 23, 78(6):1039-1049.
21. Si X., Luo H., Morgan A., Zhang J., Wong J., Yuan J., et al. Stress-activated protein kinases are involved in coxsackievirus B3 viral progeny release. J Virol 2005, 79:13875-13881.
22. Dorner A., Wegmann F., Butz S., Wolburg-Buchholz K., Wolburg H., Mack A., et al. Coxsackie-adenovirus receptor (CAR) is essential for early embryonic cardiac development. J Cell Sci 2005, 118:3509-3521.
23. Asher D., Cerny A., Weiler S., Horner J., Keeler M., Neptune M., et al. Coxackie and adenovirus receptor is essential for cardiomyocyte development. Genesis 2005, 42:77-85.
24. Chen J., Zhou B., Yu Q., Shin S., Jiao K., Schneider M., et al. Cardiomyocyte-specific deletion of the coxsackievirus and adenovirus receptor results in hyperplasia of the embryonic left ventricle and abnormalities of sinuatrial valves. Circ Res 2006, 98:923-930.
25. Lim B.-K., Xiong D., Dorner A., Youn T.-J., Yung A., Liu T., et al. Coxsackievirus and adenovirus receptor (CAR) mediates atrioventricular-node function and connexin 45 localization in the murine heart. J Clin Invest 2008, 118:2758-2770.
26. Caruso L., Yuen S., Smith J., Husain M., Opavsky M. Cardiomyocyte-targeted overexpression of the coxsackie-adenovirus receptor causes a cardiomyopathy in association with β-catenin signaling. J Mol Cell Cardiol 2010, 48:1194-1205.
27. Mungrue I., Gros R., You X., Pirani A., Azad A., Csont T., et al. Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, and sudden death. J Clin Investig 2002, 109:735-743.
28. Ju H., Gros R., You X., Tsang S., Husain M., Rabinovitch M. Conditional and targeted overexpression of vascular chymase causes hypertension in transgenic mice. Proc Natl Acad Sci USA 2001, 98(13):7469-7474.
29. Parker T.G., Packer S.E., Schneider M.D. Peptide growth factors can provoke "fetal" contractile protein gene expression in rat cardiac myocytes. J Clin Invest 1990, 85:507-514.
30. Dong R., Liu P., Wee L., Butany J., Sole M. Verapamil ameliorates the clinical and pathological course of murine myocarditis. J Clin Invest 1992, 90:2022-2030.
31. Opavsky M.A., Penninger J., Aitken K., Wen W.-H., Dawood F., Mak T., et al. Susceptibility to myocarditis is dependent on the response of alpha beta T lymphocytes to coxsackieviral infection. Circ Res 1999, 85:551-558.
32. Sun M., Dawood F., Wen W., Chen M., Dixon I., Kirshenbaum L., et al. Excessive tumor necrosis factor activation after infarction contributes to susceptibility of myocardial rupture and left ventricular dysfunction. Circulation 2004, 110:3221-3228.
33. Pfaffl M. A new mathematical model for relative quantification in real-time RT-PCR. Nuc Acids Res 2001, 29(2):2002-2007.
34. Spandidos A., Wang X., Wang H., Dragnev S., Thurber T., Seed B. A comprehensive collection of experimentally validated primers for polymerase chain reaction quantitation of murine transcript abundance. BMC Genomics 2008, 9:633.
35. Wang X., Seed B. A PCR primer bank for quantitative gene expression analysis. Nuc Acids Res 2003, 31(24). e154;1-8.
36. Opavsky M.A., Trinidad C., Martino T., Liu P. Coxsackie-adenovirus receptor isoforms. J Amer Coll Cardiol 2002, 39(Suppl A):144A.
37. Yin T., Sandhu G., Wolfgang C.D., Burrier A., Webb R.L., Rigel D.F., et al. Tissue-specific pattern of stress kinase activation in ischemic/reperfused heart and kidney. J Biol Chem 1997, 272(32):19943-19950. 1997 August 8.
38. Sasse A., Wallich M., Ding Z., Goedecke A., Schrader J. Coxsackie-and-adenovirus receptor mRNA expression in human heart failure. J Gene Med 2003, 5:876-882.
39. Noutsias M., Fechner H., de Jonge H., Wang X., Dekkers D., Houtsmuller A., et al. Human coxsackie-adenovirus receptor is colocalized with integrins alpha(v)beta(3) and alpha(v)beta(5) on the cardiomyocyte sarcolemma and upregulated in dilated cardiomyopathy:implications for cardiotropic viral infections. Circulation 2001, 104:275-280.
40. Honda T., Saitoh H., Masuko M., Katagiri-Abe T., Tominaga K., Kozakai I., et al. The coxsackievirus-adenovirus receptor protein as a cell adhesion molecule in the developing mouse brain. Brain Res Mol Brain Res 2000, 77(1):19-28.
41. Kashimura T., Kodama M., Hotta Y., Hosoya J., Yoshida K., Ozawa T., et al. Spatiotemporal changes of coxsackievius and adenovirus receptor in rat hearts during postnatal development and in cultured cardiomyocytes of neonatal rat. Virchows Arch 2004, 444:283-292.
42. Farmer C., Morton P., Snippe M., Santis G., Parsons M. Coxsackie adenovirus receptor (CAR) regulates integrin function through activation of p44/p42 MAPK. Exp Cell Res 2009, 315:2637-2647.
43. Huang G., Shi L.Z., Chi H. Regulation of JNK and p38 MAPK in the immune system: signal integration, propagation and termination. Cytokine 2009 Dec, 48(3):161-169.
44. Ashwell J. The many paths to p38 mitogen-activated protein kinase activation in the immune system. Nat Rev 2006, 6:532-540.
45. Mitchell S., Ota A., Foster W., Zhang B., Fang Z., Patel S., et al. Distinct gene expression profiles in adult mouse heart following targeted MAP kinase activation. Physiol Genomics 2006, 25:50-59.
46. Rincon M., Davis R. Regulation of the immune response by stress-activated protein kinases. Immunol Rev 2009, 228:212-224.
47. Roy P., Rashid F., Bragg J., Ibdah J. Role of the JNK signal transduction pathway in inflammatory bowel disease. World J Gastroenterol 2008, 14:200-202.
48. Manning A., Davis R. Targeting JNK for thereapeutic benefit: from junk to gold?. Nat Rev 2003, 2:554-565.
49. Tamanini A., Nicolis E., Bonizzato A., Bezzerri V., Melotti P., Assael B.M., et al. Interaction of adenovirus type 5 fiber with the coxsackievirus and adenovirus receptor activates inflammatory response in human respiratory cells. J Virol 2006 Nov, 80(22):11241-11254.
50. Tenhunen O., Rysa J., Ilves M., Soini Y., Ruskoaho H., Leskinen H. Identification of cell cycle regulatory and inflammatory genes as predominant targets of p38 mitogen-activated protein kinase in the heart. Circ Res 2006, 99:485-493.
51. Mosser D., Edwards J. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008, 8:958-969.
52. Kolattukudy P.E., Quach T., Bergese S., Breckenridge S., Hensley J., Altschuld R., et al. Myocarditis induced by targeted expression of the MCP-1 gene in murine cardiac muscle. Am J Pathol 1998 Jan, 152(1):101-111.
53. Shen Y., Xu W., Chu Y.-W., Wang Y., Liu Q.-S., Xiong S.-D. Coxsackievirus Group B type 3 infection upregulates expression of monocyte chemoattractant protein 1 in cardiac myocytes, which leads to enhanced migration of mononuclear cells in viral myocarditis. J Virol 2004, 78:12548-12556.
54. Dorner A., Grunert H.-P., Lindig V., Chandreasekharan K., Fechner H., Knowlton K., et al. Treatment of coxsackievirus-B3-infected BALB/c mice with the soluble coxsackie adenovirus receptor CAR4/7 aggravates cardiac injury. J Mol Med 2006, 84:842-851.
55. Pinkert S., Sestermann D., Wang X., Klingel K., Dorner A., Savvatis K., et al. Prevention of cardiac dysfunction in acute coxsackievirus B3 cardiomyopathy by inducible expression of a soluble coxsackievirus-adenovirus receptor. Circulation 2009, 120:2358-2366.
56. Luissint A.-C., Lutz P., Calderwood D., Couraud P.-O., Bourdoulous S. JAM-L mediated leukocyte adhesion to endothelial cells is regulated in cis by a4b1 integrin activation. J Cell Biol 2008, 183:1159-1173.